Fellows: Beyond the Programme

The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics ran for almost seven years coming to an end in July 2017. All 13 Fellows were awarded PhDs and many of them go on to be successful in their developing research careers.

All Fellows benefited greatly from being part of the Scheme, citing in particular the teaching programme and the mutual support of their peers on the programme as being particularly advantageous in their success.

Tim Felton: October 2010 - September 2013

Antimicrobial therapy for ventilator associated pneumonia: improving clinical outcomes using a translational pharmacological approach.

Amy Foulkes: January 2011 - December 2013

Optimisation of biological therapies for the treatment of psoriasis by the application of pharmacogenomics.

Sam Nightingale: October 2010 - September 2013

The role of the central nervous system as a sanctuary site for HIV due to limited penetration of antiretroviral drugs.

Richard Kia: October 2011 - September 2014

Evaluation of the potential application of induced pluripotent stem cells derived from human primary somatic cells as a model for the study of idiosyncratic drug-induced liver Injury.

Stephen McWilliam: October 2011 - September 2014

Aminoglycoside-induced nephrotoxicity in children with cystic fibrosis: developing novel methods for diagnosis and intervention.

Sarah Skeoch: October 2011 - September 2014

Investigation of atherosclerosis and the effects of anti inflammatory therapy on plaque morphology in patients with rheumatoid arthritis.

John Reynolds: October 2011 - September 2014

Vitamin D as a Modifier of Endothelial Dysfunction and Drug Response in Patients with Systemic Lupus Erythematosus (SLE).

Meghna Jani: August 2012 - July 2015

Investigation of immunogenicity in response to biological therapy for autoimmune disease.

James McCaffrey: September 2012 - October 2015

Podocyte-specific glucocorticoid effects in childhood nephrotic syndrome.

James Bluett: February 2013 - January 2016

Investigating Treatment Response and Adverse Events to Methotrexate in Patients with Rheumatoid Arthritis

Richard Turner: August 2014 - July 2017

Statin-induced muscle toxicity: evaluating the functional effects of variability in P450 oxidoreductase

Back to: North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics